As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 5/10/24  Rothblatt Martine A               4          Dir.,Off.²  1:24K  United Therapeutics Corp.         SEC Connect              
  5/8/24  Rothblatt Martine A               4          Dir.,Off.²  1:13K  United Therapeutics Corp.         SEC Connect              
  5/7/24  Benkowitz Michael                 4          Officer²    1:7K   United Therapeutics Corp.         SEC Connect              
  5/7/24  Rothblatt Martine A               4          Dir.,Off.²  1:26K  United Therapeutics Corp.         SEC Connect              
  5/6/24  Causey Christopher                4          Director²   1:6K   United Therapeutics Corp.         SEC Connect              
  5/6/24  Olian Judy D.                     4          Director²   1:12K  United Therapeutics Corp.         SEC Connect              
  5/6/24  Sullivan Louis W                  4          Director²   1:8K   United Therapeutics Corp.         SEC Connect              
  5/3/24  Rothblatt Martine A               4          Dir.,Off.²  1:33K  United Therapeutics Corp.         SEC Connect              
  5/3/24  Causey Christopher                144                    1:4K   United Therapeutics Corp.         Morgan Stanley … Svcs/FA 
  5/3/24  Olian Judy D.                     144                    1:5K   United Therapeutics Corp.         Morgan Stanley … Svcs/FA 
  5/3/24  Sullivan Louis W                  144                    1:4K   United Therapeutics Corp.         Morgan Stanley … Svcs/FA 
  5/1/24  Rothblatt Martine A               4          Dir.,Off.²  1:20K  United Therapeutics Corp.         SEC Connect              
  5/1/24  United Therapeutics Corp.         8-K:2,9      5/1/24   11:390K                                                            
  5/1/24  United Therapeutics Corp.         10-Q        3/31/24   78:8.1M                                                            
 4/29/24  Rothblatt Martine A               4          Dir.,Off.²  1:17K  United Therapeutics Corp.         SEC Connect              
 4/29/24  United Therapeutics Corp.         ARS        12/31/23    1:1.9M                                                            
 4/29/24  United Therapeutics Corp.         DEFA14A                1:2.6M                                                            
 4/29/24  United Therapeutics Corp.         DEF 14A     6/26/24    9:57M                                                             
 4/25/24  Rothblatt Martine A               4          Dir.,Off.²  1:22K  United Therapeutics Corp.         SEC Connect              
 4/23/24  Dwek Raymond                      4          Director²   1:7K   United Therapeutics Corp.         SEC Connect              

____________
¹	Filing/Form Types:  -K
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-Q	Quarterly Report — Form 10-Q.
	144	Notice of a Proposed Sale of Securities by an Insider — Form 144 { The Filer is an Insider² of the Issuer }.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.